1. Unit startpage
  2. Employees
  3. Henrike Bruckmüller
Bilde av Bruckmüller, Henrike
Bilde av Bruckmüller, Henrike
Cell Signaling and Targeted Therapy henrike.bruckmuller@uit.no

Henrike Bruckmüller

  • Meike Kaehler, Merit Litterst, Julia Kolarova, Ruwen Bohm, Henrike Bruckmüller, Ole Ammerpohl et al.:
    Genome-wide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitor-resistant CML cells
    Oncology Reports 2022 ARKIV / DOI
  • Henrike Bruckmüller, Ingolf Cascorbi :
    ABCB1, ABCG2, ABCC1, ABCC2 and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
    Expert Opinion on Drug Metabolism & Toxicology 2021 DOI
  • Henrike Bruckmüller, Ingolf Cascorbi :
    Drug-Drug-Gene Interactions: A Call for Clinical Consideration
    Clinical Pharmacology and Therapeutics 2021 ARKIV / DOI
  • Charles Awortwe, Henrike Bruckmüller, Meike Kaehler, Ingolf Cascorbi :
    Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters
    Molecular Pharmaceutics 2021 ARKIV / DOI
  • Anup Shrestha, Henrike Bruckmüller, Hanne Kildalsen, Gurjit Kaur, Matthias Gaestel, Hilde Ljones Wetting et al.:
    Phosphorylation of steroid receptor coactivator-3 (SRC-3) at serine 857 is regulated by the p38 MAPK-MK2 axis and affects NF-κB-mediated transcription
    Scientific Reports 2020 ARKIV / DOI
  • Theresa Klümper, Henrike Bruckmüller, Tobias Diewock, Meike Kaehler, Sierk Haenisch, Christiane Pott et al.:
    Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance
    Experimental hematology and oncology 2020 DOI
  • Juliane Sachau, Henrike Bruckmüller, Janne Gierthmühlen, Walter Magerl, Denisa May, Julia Forstenpointner et al.:
    The serotonin receptor 2A (HTR2A) rs6313 variant is associated with higher ongoing pain and signs of central sensitization in neuropathic pain patients
    European Journal of Pain 2020 ARKIV / DOI
  • Charles Awortwe, Henrike Bruckmüller, Ingolf Cascorbi :
    Interaction of herbal products with prescribed medications: A systematic review and meta-analysis
    Pharmacological Research 2019 DOI
  • Vicki Waetzig, Wiebke Haeusgen, Cordula Andres, Sonja Frehse, Kirstin Reinecke, Henrike Bruckmüller et al.:
    Retinoic acid-induced survival effects in SH-SY5Y neuroblastoma cells
    Journal of Cellular Biochemistry 2019 DOI
  • Susanne Brueck, Henrike Bruckmüller, Danilo Wegner, Diana Busch, Paul Martin, Stefan Oswald et al.:
    Transcriptional and Post-Transcriptional Regulation of Duodenal P-Glycoprotein and MRP2 in Healthy Human Subjects after Chronic Treatment with Rifampin and Carbamazepine
    Molecular Pharmaceutics 2019 DOI
  • Nasir Ali Afsar, Henrike Bruckmüller, Anneke Nina Werk, Muhammed Kashif Nisar, H R Ahmad, Ingolf Cascorbi :
    Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population
    Scientific Reports 2019 DOI
  • Juliane Sachau, Henrike Bruckmüller, Janne Gierthmühlen, Walter Magerl, Meike Kaehler, Sierk Haenisch et al.:
    SIGMA-1 Receptor Gene Variants Affect the Somatosensory Phenotype in Neuropathic Pain Patients
    Journal of Pain 2019 DOI
  • Pascal Erdmann, Henrike Bruckmüller, Paul Martin, Diana Busch, Sierk Haenisch, Janett Müller et al.:
    Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis
    Journal of Pharmaceutical Sciences 2019 DOI
  • Meike Kaehler, Johanna Ruemenapp, Daniel Gonnermann, Inga Nagel, Oliver Bruhn, Sierk Haenisch et al.:
    MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells
    OncoTarget 2017 DOI

    • The 50 latest publications is shown on this page. See all publications in Cristin here →